|Day Low/High||35.80 / 36.08|
|52 Wk Low/High||30.20 / 40.43|
Activist investors have helped smaller shareholders win higher valuations for their holdings.
Paul Singer's Elliott is said to have started building a stake in the maker of artificial hips and knees, sending shares higher.
UK-based global medical technology company, Smith & Nephew, joins investor syndicate
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial 1 concluding that, in the patients studied, the use of the PICO Single Use...
The FTSE 100 lagged its counterparts on Thursday following a run of broker downgrades and after a stronger pound ate into FX gains for London's blue chips.
Investors should look at cheap, inflation-proof stocks, which could be very cheap.
When interest rates rise, these quality dividend growth stocks should weather the storm.
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, highlights three scientific symposia at World Union of Wound Health Societies (WUWHS) on 25-29 September 2016 in Florence, Italy.
The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of...
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.
The medical device company is spending $350 million for the gynecology business of Smith & Nephew, and has agreed to invest in an Israeli spinal robotics company.
The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.
Medical device company Stryker is paying $1.2 billion cash for defibrillator maker Physio-Control on the heels of spending $2.8 billion on disposable health care devices manufacturer Sage Products.
Kraft Heinz is the new king of the packaged-food aisle and ConforMis' shares can go higher, Cramer says.
A possible Greek deal and J&J, JPMorgan and Honeywell earnings, among many others, are on Cramer's calendar for next week.
European stocks rose on Tuesday after Greece offered concessions to its international creditors at an emergency summit, stoking hopes of a debt deal within the next two days.
TheStreet highlights 3 stocks pushing the health services industry higher today.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Smith & Nephew (LSE:SN) (NYSE:SNN), the global medical technology business, announces the conclusion of the 6th International Negative Pressure Wound Therapy (NPWT) Expert Meeting.
After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.
TheStreet highlights 3 stocks pushing the health services industry lower today.
Here's why investors should avoid the stock of the British medical-device maker.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.